摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

rac-1,2-Anhydro-5-deoxycarba-α-xylo-hexofuranurono-6,3-lactone

中文名称
——
中文别名
——
英文名称
rac-1,2-Anhydro-5-deoxycarba-α-xylo-hexofuranurono-6,3-lactone
英文别名
(1aRS,1bRS,4aSR,5aRS)-hexahydro-3H-oxireno[4,5]cyclopenta[1,2-b]furan-3-one;(1R,2R,4R,6S)-3,9-dioxatricyclo[4.3.0.02,4]nonan-8-one
rac-1,2-Anhydro-5-deoxycarba-α-xylo-hexofuranurono-6,3-lactone化学式
CAS
——
化学式
C7H8O3
mdl
——
分子量
140.139
InChiKey
SQHCOEHIVQVUBS-ZXMNWKEDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0
  • 重原子数:
    10
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.86
  • 拓扑面积:
    38.8
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    rac-1,2-Anhydro-5-deoxycarba-α-xylo-hexofuranurono-6,3-lactone高氯酸 作用下, 反应 12.0h, 以84%的产率得到rac-5-Deoxycarba-β-xylo-hexofuranurono-6,3-lactone
    参考文献:
    名称:
    Synthesis of All Stereoisomeric Carbapentofuranoses
    摘要:
    All carbocyclic analogs of the pentofuranoses were synthesized starting from norborn-5-en-2-one (1). By using either base- or acid-catalyzed Baeyer-Villiger reaction of 1, the central intermediates 2 and 3 were obtained. The required functionalization of the olefinic double bond was achieved either by cis-hydroxylation in the case of the ribo, lyre, and alpha-xylo derivatives or by epoxidation and subsequent opening with aqueous perchloric acid. In the latter case, a pronounced selectivity for opening the epoxy alcohol in the 3-position was found. If an epoxy acetate with both functions on the same side of the ring was used, the epoxide was opened in the 2-position by neighboring group participation of the acetate. The requisite side chain degradation was accomplished either by conversion of the ester into an olefin and subsequent dihydroxylation/cleavage reaction or by Curtius rearrangement to the amine and its conversion into an acetate.
    DOI:
    10.1021/jo00121a046
  • 作为产物:
    描述:
    cis-3,3a,4,6a-tetrahydro-2H-cyclopenta[b]furan-2-one 在 间氯过氧苯甲酸 作用下, 以 为溶剂, 反应 3.0h, 生成 rac-1,2-Anhydro-5-deoxycarba-α-xylo-hexofuranurono-6,3-lactone
    参考文献:
    名称:
    [EN] NITROOXY CYCLOALKANE DERIVATIVES
    [FR] DÉRIVÉS DE NITROOXY CYCLOALCANE
    摘要:
    一种具有以下结构的化合物,其中Y选择自- C(O)OR2,- C(O)NHR8,- C(CH2)1-2OR3,OH等组成的群体,或其药用盐,并使用这些化合物治疗高血压的方法。
    公开号:
    WO2010062415A1
点击查看最新优质反应信息

文献信息

  • Synthesis of Carbasugars from Aldonolactones: Ritter-Type Epoxide Opening in the Synthesis of Polyhydroxylated Aminocyclopentanes
    作者:Steen K. Johansen、Hanne T. Kornø、Inge Lundt
    DOI:10.1055/s-1999-3690
    日期:1999.1
    Using the cis-fused cyclopentane-1,4-lactone, (1R,5S,7R,8R)-7,8-dihydroxy-2-oxabicyclo[3.3.0]oct-3-one (1), as starting material, 5-deoxycarba-β-l-xylo-hexofuranose (6) together with α- (12) and β-1-amino-1,5-dideoxycarba-l-xylo-hexofuranose (16) have been prepared using a number of stereoselective transformations. The key step was the regioselective opening of the epoxide (1R,5S,7R,8R)-7,8-epoxy-2-oxabicyclo-[3.3.0]oct-3-one (4) with different nucleophiles.
    以顺式融合的环戊烷-1,4-内酯 (1R,5S,7R,8R)-7,8-二羟基-2-氧杂双环[3.3.以辛-3-酮 (1) 为起始原料,通过一系列立体选择性转化,制备出了 5-脱氧卡巴-δ-l-氧基六呋喃糖 (6) 以及δ-(12) 和 δ-1-基-1,5-二脱氧卡巴-l-氧基六呋喃糖 (16)。关键步骤是用不同的亲核剂打开环氧化物 (1R,5S,7R,8R)-7,8-环氧-2-氧杂二环-[3.3.0]辛-3-酮 (4)。
查看更多

同类化合物

马桑宁内酯 薁并[6,5-b]呋喃-2,4-二酮,十氢-5-(3-羟基丙氧基)-3a,4a-二甲基- 苦毒浆果[木防已属] 苦亭 艾瑞布林中间体 艾瑞布林 甲磺酸艾日布林 木防己苦毒宁 呋喃并[4,3,2-ij][2]苯并吡喃-2,7-二酮,2a,3,4,6,8a,8b-六氢-6-甲基-5-[(1S)-1,3,3-三甲基环己基]-,(2aR,6R,8aS,8bR)- 全内酯 二氢苦毒宁 6-甲基-4-氧代-4H-呋喃并[3,2-c]吡喃-3-甲酰氯 6-(4-羟基苯基)-2,3,3-三甲基-2H-呋喃并[5,4-b]吡喃-4-酮 4H-呋喃并[2,3-c]吡喃基莫匹罗星钠 3-甲基2H-呋喃并[2,3-c]吡喃-2-酮 3,5-二甲基2H-呋喃并[2,3-c]吡喃-2-酮 2H-呋喃并[2,3-c]吡喃-2-酮 2-[(1E,3E)-己-1,3-二烯基]-2,6-二甲基-5,6-二氢呋喃并[5,4-b]吡喃-3,4-二酮 (3aS,5S,6R,9E,14R,15R,15aR)-2,3,3a,4,5,6,7,8,11,12,13,14,15,15alpha-十四氢-6,10,14-三甲基-3-亚甲基-2-氧代-5,15-环氧环十四烷并[b]呋喃-6-醇乙酸酯 (3aR,4S,7aR)-4-羟基-3,3a,4,7a-四氢呋喃并[5,4-b]吡喃-2-酮 (3aα,3bβ,6aβ,7aα)-(+/-)-hexahydro-6-hydroxy-3a-(phenylmethyl)difuro<2,3-b:3',4'-d>furan-2(3H)-one (2R,3aS,4S,6S,7aR)-3a-benzyloxy-6-ethynyl-2-methoxy-4-p-methoxybenzyloxyhexahydrofuro[2,3-b]pyran (1R,2S,6S,7S)-5,6-Dimethoxy-8-oxo-3,9-dioxa-tricyclo[5.2.2.02,6]undeca-4,10-diene-10-carboxylic acid methyl ester N3,5'-Cyclo-2',3'-O-isopropyliden-8-oxyguanosin (3aR,4aR,7aS,8aS)-2-Thioxo-hexahydro-furo[3',4':4,5]benzo[1,2-d][1,3]dioxol-5-one 9-(3',5'-O-Isopropyliden-2-keto-β-D-xylofuranosyl)-adenin (1aR,1bS,4aS,5aS)-1a-Isopropyl-hexahydro-1,4-dioxa-cyclopropa[a]pentalen-3-one [(3aR,4S,6R,7S,7aR)-7-acetyloxy-2-oxo-4-phenylsulfanyl-3,3a,4,6,7,7a-hexahydropyrano[3,4-d][1,3]oxazol-6-yl]methyl acetate (2R,3R,3aS,6R,7R,7aR)-7-azido-6-methoxy-2-phenylsulfanyl-hexahydrofuro[3,2-b]pyran-3-ol 7-Dihydroxymethyl-O1,O2-isopropyliden-3,7-anhydro-6-desoxy-D-glucofuranose (1S,2S,6S,7R)-5,6-Dimethoxy-8-oxo-3,9-dioxa-tricyclo[5.2.2.02,6]undeca-4,10-diene-10-carboxylic acid methyl ester (2R,3S)-2-Methyl-4-oxo-oxetane-3-carboxylic acid (1R,5S)-6-methylene-3-oxo-bicyclo[3.2.1]oct-1-ylmethyl ester 3-C-(3,4,6-tri-O-acetyl-2-deoxy-2-tetrachlorophthalimido-β-D-glucopyranosyl)-1-propene (2R,4aR,5aS,8aS,9S,9aR)-5a-methoxy-7-oxo-2-phenyloctahydrofuro[2',3':5,6]pyrano[3,2-d][1,3]dioxin-9-yl acetate (4R,5E,7R,9S,10S,11E,14S)-9-((benzyloxy)methoxy)-4,10-bis((tert-butyldimethylsilyl)oxy)-7-(dimethoxymethyl)-14-(furan-3-yl)-6,12-dimethyloxacyclotetradeca-5,11-dien-2-one 3-Furan-3-yl-8-methyl-5-(4,5,6,7-tetrahydro-isobenzofuran-4-yl)-2,7-dioxa-bicyclo[3.2.1]octane methyl 2,3"-anhydro-4,6-O-benzylidene-3-C-[2,2-dihydroxyethyl]-α-D-glucopyranoside (3aR,5S,6S,7aR)-5-((R)-but-3-en-2-yl)-6-hydroxyhexahydro-2H-furo[3,2-b]pyran-2-one 7-(3-Furan-3-yl-8-methyl-2,7-dioxa-bicyclo[3.2.1]oct-5-yl)-1,3,4,5,6,7-hexahydro-isobenzofuran-1-ol